| Name | Professional Eyecare |
|---|---|
| Organization Name | Roger C. Mc Cartney, O.d.,and Brandon A. Blair, O.d.,p.c. |
| Location | 1511 M St, Ord, Nebraska 68862 |
| Type | Supplier |
| Phone | (308) 728-3229 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Although traditionally understood to induce death in cancer cells, researchers at The University of Texas MD Anderson Cancer Center have discovered that the DAPK1 protein is actually essential for growth in breast and other cancers with mutations in the TP53 gene. This discovery indicates DAPK1 may be a promising new therapeutic target for many of the most aggressive cancers.
Excess nutrients, such as fat and sugar, don't just pack on the pounds but can push some cells in the body over the brink. Unable to tolerate this "toxic" environment, these cells commit suicide.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced receipt from Mallinckrodt Inc., a Covidien company (Covidien), of top-line results from a Phase 2 study conducted by Covidien, of twice-daily administration of PENNSAID Viscous Solution (topical diclofenac sodium viscous solution) 2% w/w, previously referred to as PENNSAID Gel.
A Clemson biochemist has received grants totaling $787,000 to study how cells repair damaged DNA, which can cause cancer and genetic illnesses. The U.S. Department of Defense (DoD) and the National Institutes of Health (NIH) awarded Weiguo Cao three-year funding to investigate two DNA repair pathways.
Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.
› Verified 2 days ago
News Archive
Although traditionally understood to induce death in cancer cells, researchers at The University of Texas MD Anderson Cancer Center have discovered that the DAPK1 protein is actually essential for growth in breast and other cancers with mutations in the TP53 gene. This discovery indicates DAPK1 may be a promising new therapeutic target for many of the most aggressive cancers.
Excess nutrients, such as fat and sugar, don't just pack on the pounds but can push some cells in the body over the brink. Unable to tolerate this "toxic" environment, these cells commit suicide.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced receipt from Mallinckrodt Inc., a Covidien company (Covidien), of top-line results from a Phase 2 study conducted by Covidien, of twice-daily administration of PENNSAID Viscous Solution (topical diclofenac sodium viscous solution) 2% w/w, previously referred to as PENNSAID Gel.
A Clemson biochemist has received grants totaling $787,000 to study how cells repair damaged DNA, which can cause cancer and genetic illnesses. The U.S. Department of Defense (DoD) and the National Institutes of Health (NIH) awarded Weiguo Cao three-year funding to investigate two DNA repair pathways.
Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.
› Verified 2 days ago
Anderson Pharmacy Type: Medicare Supplier Location: 1429 M St, Ord, Nebraska 68862 Phone: (308) 728-5922 | |
Good Life Health Services Type: Long Term Care Pharmacy Location: 125 S 16th, Ord, Nebraska 68862 Phone: (308) 728-3295 | |
Professional Eyecare Type: Medicare Supplier Location: 1511 M St, Ord, Nebraska 68862 Phone: (308) 728-3229 |